La Nasa G, Carcassi C, Cirillo R, Mulargia M, Leone A L, Vacca A, Pizzati A, Boero R, Arras M, Porcella R
Istituto di Clinica Medica, Cattedra di Genetica Medica, Università di Cagliari, Italy.
Dis Markers. 1990 Nov-Dec;8(6):333-40.
This study was carried out in Sardinia, an Italian region with a very high IDDM incidence. HLA class I and class II antigens were studied in 97 unrelated IDDM patients, 33 complete families with at least one affected member each, and 559 healthy controls. Molecular typing of the DQB1 alleles was carried out in 31 patients and 61 controls. The haplotypes were determined by family studies. The HLA-DR3, DQw2, and DR4 antigens were positively associated with IDDM. The DR3 antigen was nearly always associated to B18 and frequently carried by the extended haplotype A30 Cw5 B18 3F130 DR3 DQw2. The genotype analysis of the patients showed a strong increase of the DR3/DR4 heterozygotes with a relative risk higher than that of the DR3 and DR4 homozygotes. The DR2 antigen was negatively associated with IDDM in the central island districts but not in the southern districts. The DQB1 molecular analysis showed only three alleles in the patients: DQB10201 (75.8 per cent), DQB10302 (16.1 per cent), and DQB10502 (8.1 per cent). These alleles are non Asp 57, so it would seem that nearly if not all Sardinian IDDM patients are NA/NA homozygotes. The DQB10502 allele, extremely rare in other Caucasian populations, represents in Sardinia about 70 per cent of the HLA-DR2 haplotypes, contributing to the increase of the pool of IDDM susceptible genes. Moreover it is carried in 27 per cent of the DR2 positive individuals with the extended haplotype A2 Cw7 Bw58 3F31 DR2 DQw1.AZH.
本研究在撒丁岛开展,撒丁岛是意大利一个IDDM发病率极高的地区。对97例无亲缘关系的IDDM患者、33个每个家庭至少有一名患病成员的完整家庭以及559名健康对照者进行了HLAⅠ类和Ⅱ类抗原研究。对31例患者和61名对照者进行了DQB1等位基因的分子分型。通过家系研究确定单倍型。HLA - DR3、DQw2和DR4抗原与IDDM呈正相关。DR3抗原几乎总是与B18相关联,并经常由扩展单倍型A30 Cw5 B18 3F130 DR3 DQw2携带。患者的基因型分析显示DR3/DR4杂合子显著增加,相对风险高于DR3和DR4纯合子。DR2抗原在该岛中部地区与IDDM呈负相关,但在南部地区并非如此。DQB1分子分析显示患者中只有三个等位基因:DQB10201(75.8%)、DQB10302(16.1%)和DQB10502(8.1%)。这些等位基因在第57位不是天冬氨酸,因此似乎几乎所有撒丁岛IDDM患者都是NA/NA纯合子。DQB10502等位基因在其他白种人群中极为罕见,在撒丁岛约占HLA - DR2单倍型的70%,导致IDDM易感基因库增加。此外,在27%的携带扩展单倍型A2 Cw7 Bw58 3F31 DR